Under the rapid growth of the big health market, pharmaceutical machinery enterprises are actively laying out

【Pharmaceutical Network Industry News】Driven by multiple favorable factors such as policy guidance, public health demand, and health awareness improvement, the development of China's big health industry is continuing to improve
.
At present, attracted by the vast market, a large number of enterprises are actively laying out the health industry
.
At present, the choice of most enterprises is mainly to rely on the original brand reputation, constantly enrich and expand the application scenarios, and transform into fast-moving consumer goods such as cosmeceuticals and daily chemicals
.
Under the rapid growth of the big health market, pharmaceutical machinery enterprises are actively laying out (Source: Pharmaceutical Network) At present, with the implementation of the "Healthy China Action (2019-2030)", health management has risen to the national strategic level
in China.
Under the background of the intensification of aging, the improvement of people's living standards and the continuous upgrading of consumption concepts, the industry expects that the development of the big health industry will accelerate and the market will further grow
.
It is worth noting that in this context, as far as the pharmaceutical industry is concerned, the development space of the industry will also be very broad
.
The industry believes that only by keeping up with the pace of development can the pharmaceutical-related industries further assist the pharmaceutical industry to move forward
better.
It is understood that at present, in terms of great health, pharmaceutical machinery and equipment companies have launched positive actions
.
For example, after years of development, Canaan Technology has gradually transformed from a pharmaceutical equipment factory to a smart pharmaceutical factory overall solution provider, and its revenue has increased from 184 million yuan at the beginning of the listing to 1.
06 billion yuan in 2021, and the scale effect has initially emerged
。 It is worth noting that the chairman of Canaan Technology publicly stated that in the future, in addition to continuing to deepen the pharmaceutical equipment and intelligent logistics industry and strive to become the international mainstream pharmaceutical equipment intelligent factory overall solution provider, Canaan Technology will further increase investment in the field of big health, accelerate product launch, strengthen close cooperation with leading enterprises in the industry, increase market development, and gradually promote
the big health industry based on existing customers 。 On July 10, Chutian Technology also announced that in order to build a Changsha biomedical industry chain led by the company and seize the reform and development opportunities of the national biomedical industry, the company intends to invest RMB 100 million in cash with other professional investment institutions to establish Changsha Biomedicine and Life Sciences No.
1 Private Equity Fund, and the industrial fund mainly invests in upstream and downstream related industries of the biomedical and life science industry chain (including but not limited to biomedicine, medical equipment and core components supply chain, medical devices and consumables, Medical services and great health, etc.
).

In addition, as a traditional pharmaceutical equipment enterprise, Qianyan Yam Machine has also been seeking transformation since 2014, and has launched a number of mergers and acquisitions and foreign investments in the fields of genetic testing, big health management, medical devices and other fields, and has successively set up a number of subsidiaries
.
It is reported that as early as the beginning of 2017, Hunan Qianshan Chronic Disease Health Management Co.
, Ltd.
, a subsidiary of Qianyan Medicine Machinery, released a series of big health products, taking a big step
into the field of precision medicine.
According to statistics, the market size of the big health industry has reached 7 trillion yuan in 2020, and according to this trend, the industry predicts that the market will exceed 8 trillion yuan
by 2022.
In this context, the pharmaceutical machinery and equipment industry will win more market opportunities
by taking the road of diversified development.
Disclaimer: Under no circumstances does the information herein or the opinions expressed in this article constitute investment advice
to any person.